Erasca (ERAS) Cash from Investing Activities (2020 - 2026)

Erasca (ERAS) posted Cash from Investing Activities of -$243.8 million for Q1 2026, down 1086.73% on a QoQ basis from $24.7 million in Q4 2025, and down 811.6% year-over-year from $34.3 million in Q1 2025.

Erasca (ERAS) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Erasca's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$243.8 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 811.6% year-over-year to -$243.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$177.7 million (down 34.27% YoY) and the FY2025 annual result came in at $100.4 million, up 164.12% from the prior year.
  • Cash from Investing Activities was -$243.8 million for Q1 2026 at Erasca, down from $24.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $34.3 million in Q1 2025 and bottomed at -$243.8 million in Q1 2026.
  • A 5-year average of -$27.2 million and a median of -$1.8 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 920.18% — and 2024, when it tumbled 5561.98%.
  • Erasca's Cash from Investing Activities stood at -$4.9 million in 2022, then jumped by 193.38% to $4.5 million in 2023, then surged by 397.62% to $22.6 million in 2024, then climbed by 9.26% to $24.7 million in 2025, then plunged by 1086.73% to -$243.8 million in 2026.
  • Business Quant data shows ERAS's Cash from Investing Activities at -$243.8 million in Q1 2026, $24.7 million in Q4 2025, and $25.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn - -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.43 Bn 62.43 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn -25.54 Mn
10 Erasca 5.81 Bn 5.57 Bn - -243.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -243.83 Mn
Mar 31, 2026 -243.83 Mn
Dec 31, 2025 24.71 Mn
Dec 31, 2025 24.71 Mn
Sep 30, 2025 25.70 Mn
Sep 30, 2025 25.70 Mn
Jun 30, 2025 15.75 Mn
Jun 30, 2025 15.75 Mn
Mar 31, 2025 34.27 Mn
Mar 31, 2025 34.27 Mn
Dec 31, 2024 22.62 Mn
Dec 31, 2024 22.62 Mn
Sep 30, 2024 -102.60 Mn
Sep 30, 2024 -102.60 Mn
Jun 30, 2024 -86.61 Mn
Jun 30, 2024 -86.61 Mn
Mar 31, 2024 9.97 Mn
Mar 31, 2024 9.97 Mn
Dec 31, 2023 4.55 Mn
Dec 31, 2023 4.55 Mn